Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

DWI Offenders and Their Families App for Smartphones (B-SMART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03828370
Recruitment Status : Recruiting
First Posted : February 4, 2019
Last Update Posted : May 15, 2019
Sponsor:
Collaborators:
University of New Mexico
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by (Responsible Party):
Klein Buendel, Inc.

Brief Summary:
The smart phone application (B-SMART) to be developed in this research project for family members of DWI (Driving While Intoxicated) offenders and offenders themselves will extend the impact of the Ignition Interlock Device (IID) and help DWI offenders and their families avoid drunk driving once the IID is removed from their automobiles. As such, the public health consequences of DWI, in terms of health, morbidity and mortality, and its economic and societal consequences, will be positively influenced by a highly accessible and diffusible intervention. The proposed Phase II project will complete the development and programming of the B-SMART smartphone web app and test its impact in a randomized efficacy trial with first-time DWI offenders and their concerned family members.

Condition or disease Intervention/treatment Phase
Coping Skills Family Relations Behavioral: B-SMART Intervention Group Behavioral: Usual and Customary Information Group Not Applicable

Detailed Description:
Driving while intoxicated (DWI) remains a substantial and preventable source of morbidity and mortality in the United States. A variety of sanctions and interventions have been attempted to reduce DWI in the U.S., including enhanced DWI enforcement efforts, stricter drunk driving laws, responsible alcohol beverage service training, and alcohol treatment. The Ignition Interlock Device (IID), which requires a driver to blow into a breathalyzer unit installed in an automobile to establish sobriety, reduces drunk driving while installed. The use of IIDs has become widespread: most states in the U.S. now require convicted drunk drivers to install an IID in their cars upon some form of conviction. However, research has conclusively shown that once the IIDs are removed from DWI offenders' cars, DWI recidivism levels return to those comparable to offenders who did not have an IID. Interventions are needed to increase the likelihood that the effectiveness of IIDs persists beyond the installation period. The Brief Family-Involved Treatment (B-FIT) is a promising intervention to improve DWI recidivism by affecting the social environment of DWI offenders. Proposed here is Phase II research, a continuation of the original Phase I project, that will complete the translation of B-FIT into the B-SMART mobile web app for smartphones. The content of the intervention will be based on empirically-validated couples therapy for those with alcohol use disorders developed by Co-Investigator McCrady, translated to a smartphone platform. Phase II of this project will involve the systematic completion of B-SMART, employing: 1) an Expert Advisory Board, and 2) iterative development, multimedia and usability focus groups, and interviews comprised of CFM and DWI offenders. B-SMART will be fully produced for DWI offenders and their concerned family members (CFM) and then tested in a randomized controlled efficacy trial with first-time DWI offenders (n=150) and their CFMs (n=150) recruited from the Santa Fe County DWI Program. Unique to this intervention are the involvement of family members in supporting the DWI offender to not drink and drive and the use of smartphone technology to make that support immediate, accessible, and diffusible. B-SMART will involve the CFMs by providing coping skills, communication skills, and strategies to help avoid DWI. The randomized efficacy trial of B-SMART will examine B-SMART's impact on a variety of alcohol-related dependent variables, including IID lockout events, alcohol use, and family functioning. Should B-SMART be demonstrated to impact DWI offenders and their family members by reducing IID Lockout Events (which predict future DWI recidivism) and alcohol use, and improving family functioning, DWI offenders, their families, and their communities will have an important, effective, accessible tool to further reduce the social, health and economic consequences of DWI.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The B-SMART mobile web app will be evaluated in a randomized pretest-posttest controlled design. First-time DWI offenders and their CFMs will be randomized together to the intervention (B-SMART) or a usual and customary (UC) IID information condition comparison group (n=150) following baseline assessment.
Masking: Double (Participant, Care Provider)
Primary Purpose: Supportive Care
Official Title: Smartphone Help for DWI Offenders and Their Families: A B-SMART App
Actual Study Start Date : March 30, 2019
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : August 31, 2020

Arm Intervention/treatment
Active Comparator: Usual & Customary Information Group

Study Cohort Assessment:

Baseline 3 month follow-up/ post-test 9 month follow-up/post test & Interlock Ignition Device

Behavioral: Usual and Customary Information Group
Participants randomized to the usual and customary care (UC) group will receive a website with a pamphlet on the IID installed in their vehicle and the manufacturer information provided about the IID in PDF format, in both English and Spanish. This constitutes a UC group, as such pamphlets are widely available to DWI offenders who have IIDs installed in their vehicles. Thus, providing this pamphlet represents a standard information provision for first-time DWI offenders and their CFMs.

Experimental: B-SMART Intervention Group

Study Cohort Assessment:

Baseline Web App Intervention 3 month follow-up/ post-test 9 month follow-up/post test & Interlock Ignition Device

Behavioral: B-SMART Intervention Group
The B-SMART mobile web app will contain four modules: 1) Supporting Abstinence, 2) Shared Positive Activities, 3) Common Challenges for Family Members with IID, and 4) Effective Communication. Within each module there will be a series of learning activities, including presentation text, interactive engagement, and videos. All app content will be available in both English and Spanish, based on user language preference.




Primary Outcome Measures :
  1. Measure of Primary Outcome Variable: IID Lockout Events. [ Time Frame: 9 months ]
    The primary outcome measure will be frequency of IID lockout events from baseline to 9-month follow-up post-randomization, collected from the Santa Fe DWI program database for each first-time DWI offender participant.


Secondary Outcome Measures :
  1. Measures of Secondary Outcome Variables and Mediators. [ Time Frame: 9 months ]
    Alcohol use by the DWI offender, a secondary outcome, will be assessed at baseline, 3-month follow-up, and 9-month follow-up with versions of the Form 9090,91 adapted for online assessment for the CFMs (Form 90-ACS) and first-time DWI offenders (Form 90-AF).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

DWI Offender

  • male or female
  • 21 years or older
  • first-time DWI offender with IID installed in vehicle
  • enrolled in Santa Fe County DWI Program
  • have a smartphone, tablet computer, or personal computer with Internet access
  • consent to participate
  • able to read and speak English or Spanish

Concerned Family Member (CFM):

  • male or female
  • 21 years or older
  • spouse, parent, or immediate family member of first-time DWI offender with IID installed in vehicle and enrolled in Santa Fe County DWI Program
  • have a smartphone, tablet computer, or personal computer with Internet access
  • consent to participate
  • able to read and speak English or Spanish

Exclusion Criteria:

  • other family members already enrolled in the project
  • second or above DWI conviction

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03828370


Contacts
Layout table for location contacts
Contact: Jeanny M Reither 3035654345 jreither@kleinbuendel.com
Contact: Gill Woodall, PhD 3035654321 gwoodall@kleinbuendel.com

Locations
Layout table for location information
United States, Colorado
Klein Buendel, Inc Recruiting
Golden, Colorado, United States, 80401
Contact: Jeanny Reither, MS    303-565-4345    jreither@kleinbuendel.com   
Contact: Gill Woodall, PhD    3035654321    gwoodall@kleinbuendel.com   
United States, New Mexico
University of New Mexico Not yet recruiting
Albuquerque, New Mexico, United States, 87107
Contact: Barbara McCrady, PhD    505-925-2388    bmccrady@unm.edu   
Sponsors and Collaborators
Klein Buendel, Inc.
University of New Mexico
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Investigators
Layout table for investigator information
Principal Investigator: Gill Woodall, PhD Klein Buendel, Inc.

Layout table for additonal information
Responsible Party: Klein Buendel, Inc.
ClinicalTrials.gov Identifier: NCT03828370     History of Changes
Other Study ID Numbers: 0320
2R44AA022850-02 ( U.S. NIH Grant/Contract )
First Posted: February 4, 2019    Key Record Dates
Last Update Posted: May 15, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No